BridgeMD
New treatment option for ACL Tear
Official title Quadriceps Strengthening ACL Reconstruction
ClinicalTrials.gov ID: NCT07015541
What this study is testing
- What it's testing
- The purpose of this study is to investigate the effects of quadriceps focused interventions on knee function and biomechanics in adolescent patients with anterior cruciate ligament reconstruction (ACLR)
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 13 to 17
You may be able to join if
- no history of knee injury/surgery of the contralateral limb
You likely can't join if
- (1) bilateral knee injuries
- (2) prior knee ligament injury and/or surgery
- (3) multiple ligament injuries and/or ruptures
- (4) conditions in which NMES and BFR are contraindicated
The study team makes the final eligibility decision.
Where it's taking place
- Sunnyvale, California, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 13 years to 17 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Sunnyvale, California, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.